logo-education
0370 270 6000

already registered?

Please sign in with your existing account details.

need to register?

Register to access exclusive content, sign up to receive our updates and personalise your experience on brownejacobson.com.

Privacy statement - Terms and conditions

Forgotten your password?

Shortage of places leads to more primary school appeals

5 October 2012

The number of appeals by parents challenging decisions not to award their child a place at their primary school of choice has risen for the fifth year running. A total of 46,905 appeals were made against primary school admissions, compared with 42,070 the previous year.

A new School Admissions Code was published by the Department for Education this year. Parents can appeal to an Independent Appeal Panel against a decision not to award their child a place at their preferred school. However, parents need to overcome a high hurdle to be awarded a place in infant class size appeals, as they must show the admission authority acted unreasonably. Although the number of appeals rose, under one in five parents were successful.

The problem is exacerbated by a severe shortage of primary places in some parts of England, especially London. Academies and schools who are their own admission authorities will no doubt be considering increasing their published admission number to admit more pupils to their schools.

Related opinions

Does the move into Step 4 mean the ending of Covid-19 restrictions within schools?

With the Prime Ministers announcement that he intends for Step 4 to begin on 19 July, this will also bring an end to the restrictions currently in place on education settings.

View blog

Advocacy in Action: Female Genital Mutilation Protection Orders (FGMPO)

The issue of Female Genital Mutilation Protection Orders and the importance of education providers to act promptly.

View blog

Responsibilities towards students identifying as non-binary

Our top tips for supporting transgender and non-binary pupils.

View blog

Schools face scrutiny over Covid-19 vaccinations for children

On 4 June, the Medicines and Healthcare products Regulatory Agency (MHRA) approved the use of the Pfizer/BioNTech Covid-19 vaccine for 12- to 15-year-olds.

View blog

Mailing list sign up

Select which mailings you would like to receive from us.

Sign up